在巴勒斯坦,与异氨酸治疗相关的做法,有效性和报告的副作用
Abdallah Damin Abukhalil1, Mai Yousef1, Marwa Ammar1
1Department of Pharmacy, Faculty of Pharmacy, Nursing, and Health Professions, Birzeit University, West Bank, State of Palestine.
Patient preference and adherence
|February 28, 2024
概括
这项研究发现,在巴勒斯坦,异氨酸的处方和使用存在显著差距,安全指南的遵守程度较低,并且经常出现口唇干燥和抑郁等副作用. 需要改进的协议,以确保这种药物的患者安全.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 伊索特里诺因是一种关键的治疗方法,具有严重的潜在副作用.
- 患者和医疗保健提供者遵守安全协议至关重要.
- 没有先前的研究探讨了巴勒斯坦的异丁使用情况.
研究的目的:
- 在巴勒斯坦评估异二因的临床实践.
- 评估遵守治疗指南的情况.
- 为了确定异氨酸的疗效和报告的副作用.
主要方法:
- 在巴勒斯坦的大学生中进行了一项横截面在线调查.
- 纳入了548名年龄在18岁以上的参与者,他们有异氨酸史.
- 数据使用SPSS版本27进行分析,显著性为P <0.05.
主要成果:
- 大多数参与者 (96%) 是女性;常见的副作用包括口唇干燥 (96.2%) 和抑郁症 (12%).
- 只有60.2%的皮肤科医生遵循了AAD的指导方针,48.7%的皮肤科医生订购了基线实验室.
- 很少有性活跃的女性 (6.8%) 接受怀孕测试;1.7%的药剂师遵循孕期女性的发药协议.
结论:
- 在巴勒斯坦,对异二烯的处方和患者教育需要显著改进.
- 在药房和医疗实践中调整政策和协议是必不可少的.
- 需要加强对高风险药物的监测和执法,例如异二胺.
更多相关视频
03:10Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
2.5K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
